This brand name is authorized in
The drug MINITRAN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Perphenazine
UNII FTA7XXY4EZ - PERPHENAZINE
|
|
Perphenazine is a depressant which blocks dopamine receptors in the central nervous system. It binds to dopamine D1 and D2 receptors and inhibits their activity. Its antiemetic action is mainly due to the inhibition of D2 receptors in the center of the vomiting. Perphenazine also binds to alpha adrenergic receptors and in conjunction with G proteins activate the phosphatidylinositol-calcium system. |
|
2
Amitriptyline
UNII 26LUD4JO9K - AMITRIPTYLINE HYDROCHLORIDE
|
|
Amitriptyline is a tricyclic antidepressant and an analgesic. It prevents the re-uptake, and hence the inactivation of noradrenaline and serotonin at nerve terminals. Reuptake prevention of these monoamine neurotransmitters potentiate their action in the brain. This appears to be associated with the antidepressant activity. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N06CA01 | Amitriptyline and psycholeptics | N Nervous system → N06 Psychoanaleptics → N06C Psycholeptics and psychoanaleptics in combination → N06CA Antidepressants in combination with psycholeptics |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
